Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform

OBJECTIVES: With a rapidly growing list of candidate immune‐based cancer therapeutics, there is a critical need to generate highly reliable animal models to preclinically evaluate the efficacy of emerging immune‐based therapies, facilitating successful clinical translation. Our aim was to design and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Immunology
Main Authors: Shenoy, Gautam N, Greene, Christopher J, Bhatta, Maulasri, Baroja, Miren L, Loyall, Jenni L, Balu‐Iyer, Sathy V, Kelleher, Raymond J, Carreno, Beatriz M, Linette, Gerald P, Shultz, Leonard D, Bankert, Richard B
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7853904/
https://ncbi.nlm.nih.gov/pubmed/33552509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1246
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados